Teprotumumab, New Era for Thyroid Eye Disease

Thyroid eye disease is a progression of an autoimmune disease called Graves disease, which majorly affects eye orbits and its muscular tissues. It affects the patients by acting a impact on their quality of life by acting on patients visual balance along with facial disfiguring. In this review paper I will review as the development of monoclonal antibody called teprotumumab for treatment of thyroid eye disease along with its brief mechanism of action.